 Anticoagulants
"Anticoagulants" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Agents that prevent BLOOD CLOTTING.
| Descriptor ID |
D000925
|
| MeSH Number(s) |
D27.505.954.502.119
|
| Concept/Terms |
Anticoagulants- Anticoagulants
- Anticoagulation Agents
- Agents, Anticoagulation
- Anticoagulant Agents
- Agents, Anticoagulant
- Anticoagulant Drugs
- Drugs, Anticoagulant
- Anticoagulant
|
Below are MeSH descriptors whose meaning is more general than "Anticoagulants".
Below are MeSH descriptors whose meaning is more specific than "Anticoagulants".
This graph shows the total number of publications written about "Anticoagulants" by people in this website by year, and whether "Anticoagulants" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1993 | 0 | 1 | 1 | | 1995 | 1 | 2 | 3 | | 1996 | 0 | 3 | 3 | | 1997 | 1 | 1 | 2 | | 1998 | 2 | 2 | 4 | | 1999 | 2 | 1 | 3 | | 2000 | 4 | 1 | 5 | | 2001 | 3 | 3 | 6 | | 2002 | 2 | 2 | 4 | | 2003 | 4 | 1 | 5 | | 2004 | 1 | 3 | 4 | | 2005 | 7 | 0 | 7 | | 2006 | 4 | 3 | 7 | | 2007 | 3 | 1 | 4 | | 2008 | 8 | 7 | 15 | | 2009 | 3 | 5 | 8 | | 2010 | 12 | 3 | 15 | | 2011 | 3 | 5 | 8 | | 2012 | 6 | 3 | 9 | | 2013 | 7 | 9 | 16 | | 2014 | 14 | 11 | 25 | | 2015 | 10 | 6 | 16 | | 2016 | 11 | 8 | 19 | | 2017 | 11 | 6 | 17 | | 2018 | 11 | 12 | 23 | | 2019 | 8 | 5 | 13 | | 2020 | 11 | 12 | 23 | | 2021 | 8 | 17 | 25 | | 2022 | 2 | 7 | 9 |
To return to the timeline, click here.
Below are the most recent publications written about "Anticoagulants" by people in Profiles.
-
Freeman JV, Higgins AY, Wang Y, Du C, Friedman DJ, Daimee UA, Minges KE, Pereira L, Goldsweig AM, Price MJ, Reddy VY, Gibson D, Doshi SK, Varosy PD, Masoudi FA, Curtis JP. Antithrombotic Therapy After Left Atrial Appendage Occlusion in Patients With Atrial Fibrillation. J Am Coll Cardiol. 2022 05 10; 79(18):1785-1798.
-
Friedman DJ, Du C, Wang Y, Agarwal V, Varosy PD, Masoudi FA, Holmes DR, Reddy VY, Price MJ, Curtis JP, Freeman JV. Patient-Level Analysis of Watchman Left Atrial Appendage Occlusion in Practice Versus Clinical Trials. JACC Cardiovasc Interv. 2022 05 09; 15(9):950-961.
-
Sandhu A, Varosy PD. Left atrial appendage occlusion in patients unable to tolerate anticoagulation is cost-effective in Sweden: but how generalizable is this finding? Eur Heart J. 2022 03 31; 43(13):1357-1359.
-
Lee JS, Khan AD, Brockman V, Schroeppel TJ. A "GAP" in Activation: A Better Way to Manage Geriatric and Anticoagulated Patients with Head Trauma. Am Surg. 2022 Jul; 88(7):1437-1441.
-
Berkowitz SD, Bauersachs RM, Szarek M, Nehler MR, Debus ES, Patel MR, Anand SS, Capell WH, Hess CN, Hsia J, Leeper NJ, Brasil D, Mátyás L, Diaz R, Brodmann M, Muehlhofer E, Haskell LP, Bonaca MP. Prevention of arterial and venous thrombotic events in symptomatic peripheral arterial disease patients after lower extremity revascularization in the VOYAGER PAD trial: Dual anticoagulant/antiplatelet regimen vs antiplatelet therapy alone. J Thromb Haemost. 2022 05; 20(5):1193-1205.
-
Yaghi S, Shu L, Bakradze E, Salehi Omran S, Giles JA, Amar JY, Henninger N, Elnazeir M, Liberman AL, Moncrieffe K, Lu J, Sharma R, Cheng Y, Zubair AS, Simpkins AN, Li GT, Kung JC, Perez D, Heldner M, Scutelnic A, Seiffge D, Siepen B, Rothstein A, Khazaal O, Do D, Kasab SA, Rahman LA, Mistry EA, Kerrigan D, Lafever H, Nguyen TN, Klein P, Aparicio H, Frontera J, Kuohn L, Agarwal S, Stretz C, Kala N, El Jamal S, Chang A, Cutting S, Xiao H, de Havenon A, Muddasani V, Wu T, Wilson D, Nouh A, Asad SD, Qureshi A, Moore J, Khatri P, Aziz Y, Casteigne B, Khan M, Cheng Y, Mac Grory B, Weiss M, Ryan D, Vedovati MC, Paciaroni M, Siegler JE, Kamen S, Yu S, Leon Guerrero CR, Atallah E, De Marchis GM, Brehm A, Dittrich T, Psychogios M, Alvarado-Dyer R, Kass-Hout T, Prabhakaran S, Honda T, Liebeskind DS, Furie K. Direct Oral Anticoagulants Versus Warfarin in the Treatment of Cerebral Venous Thrombosis (ACTION-CVT): A Multicenter International Study. Stroke. 2022 03; 53(3):728-738.
-
Esposito EC, Kufera JA, Wolff TW, Spalding MC, Simpson J, Dunn JA, Zier L, Burruss S, Kim P, Jacobson LE, Williams J, Nahmias J, Grigorian A, Harmon L, Gergen A, Chatoor M, Rattan R, Young AJ, Pascual JL, Murry J, Ong AW, Muller A, Sandhu RS, Appelbaum R, Bugaev N, Tatar A, Zreik K, Hustad L, Lieser MJ, Stein DM, Scalea TM, Lauerman MH. Factors associated with stroke formation in blunt cerebrovascular injury: An EAST multicenter study. J Trauma Acute Care Surg. 2022 02 01; 92(2):347-354.
-
Goldenberg NA, Kittelson JM, Abshire TC, Bonaca M, Casella JF, Dale RA, Halperin JL, Hamblin F, Kessler CM, Manco-Johnson MJ, Sidonio RF, Spyropoulos AC, Steg PG, Turpie AGG, Schulman S. Effect of Anticoagulant Therapy for 6 Weeks vs 3 Months on Recurrence and Bleeding Events in Patients Younger Than 21 Years of Age With Provoked Venous Thromboembolism: The Kids-DOTT Randomized Clinical Trial. JAMA. 2022 01 11; 327(2):129-137.
-
Hess CN, Capell WH, Bristow MR, Ruf W, Szarek M, Morrow DA, Nicolau JC, Graybill CA, Marshall D, Hsia J, Bonaca MP. Rationale and design of a study to assess the safety and efficacy of rNAPc2 in COVID-19: the Phase 2b ASPEN-COVID-19 trial. Am Heart J. 2022 04; 246:136-143.
-
Carney BJ, Wang TF, Ren S, George G, Al Homssi A, Gaddh M, Connolly GC, Shah VI, Bogue T, Bartosic A, Neuberg D, Baumann Kreuziger L, Zwicker JI. Anticoagulation in cancer-associated thromboembolism with thrombocytopenia: a prospective, multicenter cohort study. Blood Adv. 2021 12 28; 5(24):5546-5553.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|